Also from this source

You just read:

Regen BioPharma, Inc. Successfully Completes in Life Portion of Experiments Requested by FDA for HemaXellerate Pre-Clinical Study

News provided by

Regen BioPharma, Inc.

Jul 21, 2015, 08:30 ET